Compare ARVN & SMBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ARVN | SMBK |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 781.0M | 706.2M |
| IPO Year | 2018 | 2000 |
| Metric | ARVN | SMBK |
|---|---|---|
| Price | $13.49 | $40.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 21 | 4 |
| Target Price | $15.57 | ★ $38.63 |
| AVG Volume (30 Days) | ★ 743.8K | 54.0K |
| Earning Date | 05-27-2026 | 04-21-2026 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | ★ 58.84 | 26.63 |
| EPS | N/A | ★ 2.17 |
| Revenue | ★ $262,600,000.00 | N/A |
| Revenue This Year | N/A | $17.59 |
| Revenue Next Year | $1.94 | $10.30 |
| P/E Ratio | ★ N/A | $18.08 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.90 | $26.31 |
| 52 Week High | $18.93 | $43.91 |
| Indicator | ARVN | SMBK |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 46.46 |
| Support Level | $11.10 | $33.68 |
| Resistance Level | $13.97 | $40.08 |
| Average True Range (ATR) | 0.83 | 1.51 |
| MACD | 0.10 | -0.33 |
| Stochastic Oscillator | 81.83 | 39.96 |
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
SmartFinancial Inc operates as a bank holding company for SmartBank. It offers various banking and financial services to individuals and corporate customers. The principal business of the Bank consists of attracting deposits from the general public and investing those funds, together with funds generated from operations and from principal and interest payments on loans, mainly in commercial loans, commercial and residential real estate loans, consumer loans, and residential and commercial construction loans. The primary source of revenue is interest income from earning assets, namely loans and securities.